nodes	percent_of_prediction	percent_of_DWPC	metapath
Lofexidine—HTR1A—GPCR ligand binding—F2—atherosclerosis	0.00169	0.00169	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—GHRL—atherosclerosis	0.00169	0.00169	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CX3CL1—atherosclerosis	0.00168	0.00168	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ABCG1—atherosclerosis	0.00166	0.00166	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HRH1—atherosclerosis	0.00163	0.00163	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—APOA4—atherosclerosis	0.00163	0.00163	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—IGF2—atherosclerosis	0.00163	0.00163	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CNR2—atherosclerosis	0.00159	0.00159	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—APOB—atherosclerosis	0.00158	0.00158	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CCR2—atherosclerosis	0.00157	0.00157	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—EDNRA—atherosclerosis	0.00157	0.00157	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.00157	0.00157	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—FABP4—atherosclerosis	0.00156	0.00156	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—LCAT—atherosclerosis	0.00156	0.00156	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.00156	0.00156	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—CXCL8—atherosclerosis	0.00155	0.00155	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.00154	0.00154	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—APOA4—atherosclerosis	0.00153	0.00153	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—GHRL—atherosclerosis	0.00153	0.00153	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—CCL2—atherosclerosis	0.00151	0.00151	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP7A1—atherosclerosis	0.00151	0.00151	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCL4—atherosclerosis	0.0015	0.0015	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—KNG1—atherosclerosis	0.00148	0.00148	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—AGTR1—atherosclerosis	0.00147	0.00147	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—PRKCG—atherosclerosis	0.00146	0.00146	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—AGT—atherosclerosis	0.00144	0.00144	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—CD36—atherosclerosis	0.00143	0.00143	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—APOA2—atherosclerosis	0.00141	0.00141	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP27A1—atherosclerosis	0.00139	0.00139	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CCL3—atherosclerosis	0.00137	0.00137	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—EDNRA—atherosclerosis	0.00136	0.00136	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CCR2—atherosclerosis	0.00136	0.00136	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—KNG1—atherosclerosis	0.00135	0.00135	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—UTS2—atherosclerosis	0.00134	0.00134	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—AGTR1—atherosclerosis	0.00134	0.00134	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—F2—atherosclerosis	0.00133	0.00133	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—GHRL—atherosclerosis	0.00133	0.00133	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	0.00132	0.00132	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ALOX5AP—atherosclerosis	0.00132	0.00132	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ALOX15—atherosclerosis	0.00132	0.00132	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—APOA2—atherosclerosis	0.00132	0.00132	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PLA2G2A—atherosclerosis	0.00132	0.00132	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—PDGFB—atherosclerosis	0.00132	0.00132	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—MMP1—atherosclerosis	0.0013	0.0013	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ABCG5—atherosclerosis	0.0013	0.0013	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CX3CR1—atherosclerosis	0.00129	0.00129	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CASR—atherosclerosis	0.00129	0.00129	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—APOA4—atherosclerosis	0.00128	0.00128	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CX3CL1—atherosclerosis	0.00126	0.00126	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—LPA—atherosclerosis	0.00126	0.00126	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—CAV1—atherosclerosis	0.00125	0.00125	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	0.00125	0.00125	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—EDN1—atherosclerosis	0.00125	0.00125	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—APOA1—atherosclerosis	0.00125	0.00125	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—CCL5—atherosclerosis	0.00124	0.00124	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—EDNRA—atherosclerosis	0.00124	0.00124	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CCR2—atherosclerosis	0.00124	0.00124	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.00123	0.00123	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—BGN—atherosclerosis	0.00122	0.00122	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	0.00121	0.00121	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—APOA5—atherosclerosis	0.00121	0.00121	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—GHRL—atherosclerosis	0.0012	0.0012	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CNR2—atherosclerosis	0.00119	0.00119	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—CXCL8—atherosclerosis	0.00119	0.00119	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—MMP3—atherosclerosis	0.00119	0.00119	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—F2—atherosclerosis	0.00119	0.00119	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—CCL2—atherosclerosis	0.00119	0.00119	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCL4—atherosclerosis	0.00118	0.00118	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PRKCG—atherosclerosis	0.00118	0.00118	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—NOS2—atherosclerosis	0.00118	0.00118	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—KNG1—atherosclerosis	0.00116	0.00116	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PLA2G1B—atherosclerosis	0.00116	0.00116	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—AGTR1—atherosclerosis	0.00116	0.00116	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—PIK3CG—atherosclerosis	0.00114	0.00114	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—EDN1—atherosclerosis	0.00113	0.00113	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CCL5—atherosclerosis	0.00112	0.00112	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ALOX5—atherosclerosis	0.00112	0.00112	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—APOA2—atherosclerosis	0.0011	0.0011	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PRKCG—atherosclerosis	0.00107	0.00107	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—VWF—atherosclerosis	0.00106	0.00106	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—APOC3—atherosclerosis	0.00106	0.00106	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—KNG1—atherosclerosis	0.00106	0.00106	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—UTS2—atherosclerosis	0.00105	0.00105	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—LDLR—atherosclerosis	0.00105	0.00105	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—AGTR1—atherosclerosis	0.00105	0.00105	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—IGF1—atherosclerosis	0.00104	0.00104	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—AGT—atherosclerosis	0.00104	0.00104	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCL3—atherosclerosis	0.00103	0.00103	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CX3CR1—atherosclerosis	0.00101	0.00101	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CASR—atherosclerosis	0.00101	0.00101	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—NAMPT—atherosclerosis	0.00101	0.00101	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—LIPC—atherosclerosis	0.001	0.001	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—APOC3—atherosclerosis	0.000995	0.000995	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—SERPINE1—atherosclerosis	0.000991	0.000991	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CX3CL1—atherosclerosis	0.000991	0.000991	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—ALB—atherosclerosis	0.000989	0.000989	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—LDLR—atherosclerosis	0.000989	0.000989	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NCF1—atherosclerosis	0.000984	0.000984	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—EDN1—atherosclerosis	0.000981	0.000981	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CCL5—atherosclerosis	0.000974	0.000974	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CETP—atherosclerosis	0.000966	0.000966	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—F2—atherosclerosis	0.000958	0.000958	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—NOS3—atherosclerosis	0.000946	0.000946	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—AGT—atherosclerosis	0.000941	0.000941	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CNR2—atherosclerosis	0.000939	0.000939	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—CXCL8—atherosclerosis	0.000938	0.000938	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—MMP3—atherosclerosis	0.000937	0.000937	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—EDNRA—atherosclerosis	0.000929	0.000929	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCR2—atherosclerosis	0.000929	0.000929	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PRKCG—atherosclerosis	0.000926	0.000926	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CYBA—atherosclerosis	0.000925	0.000925	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—SCARB1—atherosclerosis	0.000925	0.000925	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000916	0.000916	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PLAT—atherosclerosis	0.000905	0.000905	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PARP1—atherosclerosis	0.000905	0.000905	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GHRL—atherosclerosis	0.000905	0.000905	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—EDN1—atherosclerosis	0.000891	0.000891	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CCL5—atherosclerosis	0.000884	0.000884	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—HMGCR—atherosclerosis	0.000873	0.000873	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—F2—atherosclerosis	0.00087	0.00087	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	0.000844	0.000844	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PRKCG—atherosclerosis	0.000841	0.000841	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—VWF—atherosclerosis	0.000837	0.000837	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PIK3CG—atherosclerosis	0.000832	0.000832	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—APOC3—atherosclerosis	0.000832	0.000832	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—LDLR—atherosclerosis	0.000827	0.000827	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—AGT—atherosclerosis	0.000814	0.000814	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCL3—atherosclerosis	0.000807	0.000807	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—KNG1—atherosclerosis	0.000795	0.000795	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AGTR1—atherosclerosis	0.00079	0.00079	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ABCA1—atherosclerosis	0.000778	0.000778	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CCL2—atherosclerosis	0.000775	0.000775	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NCF1—atherosclerosis	0.000773	0.000773	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PLG—atherosclerosis	0.00077	0.00077	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—F2—atherosclerosis	0.000753	0.000753	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—AGT—atherosclerosis	0.00074	0.00074	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—EDNRA—atherosclerosis	0.00073	0.00073	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCR2—atherosclerosis	0.00073	0.00073	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SOCS3—atherosclerosis	0.000729	0.000729	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CYBA—atherosclerosis	0.000727	0.000727	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PIK3CG—atherosclerosis	0.00072	0.00072	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PLAT—atherosclerosis	0.000712	0.000712	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PARP1—atherosclerosis	0.000712	0.000712	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GHRL—atherosclerosis	0.000712	0.000712	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MMP3—atherosclerosis	0.000704	0.000704	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IGF2—atherosclerosis	0.000701	0.000701	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—F2—atherosclerosis	0.000683	0.000683	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—VEGFA—atherosclerosis	0.000682	0.000682	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—APOB—atherosclerosis	0.000681	0.000681	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—CXCL8—atherosclerosis	0.000675	0.000675	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—EDN1—atherosclerosis	0.00067	0.00067	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—HMOX1—atherosclerosis	0.000668	0.000668	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCL5—atherosclerosis	0.000665	0.000665	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PIK3CG—atherosclerosis	0.000654	0.000654	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—LPL—atherosclerosis	0.00065	0.00065	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—MAPK3—atherosclerosis	0.000645	0.000645	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—APOB—atherosclerosis	0.00064	0.00064	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PRKCG—atherosclerosis	0.000632	0.000632	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—TGFB1—atherosclerosis	0.000626	0.000626	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—KNG1—atherosclerosis	0.000625	0.000625	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GSTM1—atherosclerosis	0.000622	0.000622	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AGTR1—atherosclerosis	0.000621	0.000621	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SPP1—atherosclerosis	0.000615	0.000615	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CXCL8—atherosclerosis	0.000613	0.000613	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—LPL—atherosclerosis	0.000611	0.000611	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CCL2—atherosclerosis	0.000609	0.000609	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PLG—atherosclerosis	0.000605	0.000605	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GPX1—atherosclerosis	0.000596	0.000596	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CD36—atherosclerosis	0.00058	0.00058	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SOCS3—atherosclerosis	0.000573	0.000573	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PDGFB—atherosclerosis	0.000569	0.000569	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AGT—atherosclerosis	0.000556	0.000556	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MMP3—atherosclerosis	0.000553	0.000553	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IGF2—atherosclerosis	0.000551	0.000551	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—MTHFR—atherosclerosis	0.00055	0.00055	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—LEP—atherosclerosis	0.000545	0.000545	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—APOE—atherosclerosis	0.000545	0.000545	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CAV1—atherosclerosis	0.00054	0.00054	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PPARA—atherosclerosis	0.00054	0.00054	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—APOA1—atherosclerosis	0.000538	0.000538	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—APOB—atherosclerosis	0.000535	0.000535	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CXCL8—atherosclerosis	0.00053	0.00053	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—EDN1—atherosclerosis	0.000526	0.000526	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—AGT—atherosclerosis	0.000523	0.000523	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCL5—atherosclerosis	0.000522	0.000522	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ESR1—atherosclerosis	0.00052	0.00052	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—F2—atherosclerosis	0.000514	0.000514	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—APOE—atherosclerosis	0.000512	0.000512	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—LPL—atherosclerosis	0.000511	0.000511	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CAV1—atherosclerosis	0.000507	0.000507	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—APOA1—atherosclerosis	0.000506	0.000506	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PRKCG—atherosclerosis	0.000497	0.000497	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PIK3CG—atherosclerosis	0.000492	0.000492	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SPP1—atherosclerosis	0.000484	0.000484	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CXCL8—atherosclerosis	0.000482	0.000482	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—MAPK3—atherosclerosis	0.000471	0.000471	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—INS—atherosclerosis	0.000465	0.000465	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PIK3CG—atherosclerosis	0.000462	0.000462	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCL2—atherosclerosis	0.000458	0.000458	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IGF1—atherosclerosis	0.00045	0.00045	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PDGFB—atherosclerosis	0.000448	0.000448	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PPARG—atherosclerosis	0.000446	0.000446	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—INS—atherosclerosis	0.000437	0.000437	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AGT—atherosclerosis	0.000437	0.000437	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—AKT1—atherosclerosis	0.000435	0.000435	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—APOE—atherosclerosis	0.000428	0.000428	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—LEP—atherosclerosis	0.000428	0.000428	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SERPINE1—atherosclerosis	0.000427	0.000427	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CAV1—atherosclerosis	0.000424	0.000424	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—APOA1—atherosclerosis	0.000423	0.000423	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ESR1—atherosclerosis	0.000409	0.000409	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NOS3—atherosclerosis	0.000408	0.000408	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—F2—atherosclerosis	0.000404	0.000404	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ALB—atherosclerosis	0.000401	0.000401	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PIK3CG—atherosclerosis	0.000386	0.000386	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—NOS3—atherosclerosis	0.000384	0.000384	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	0.00037	0.00037	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—INS—atherosclerosis	0.000366	0.000366	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CXCL8—atherosclerosis	0.000362	0.000362	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	0.00036	0.00036	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	0.000354	0.000354	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PTGS2—atherosclerosis	0.000351	0.000351	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—AKT1—atherosclerosis	0.00035	0.00035	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—IL6—atherosclerosis	0.000344	0.000344	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	0.000336	0.000336	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MMP9—atherosclerosis	0.000327	0.000327	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	0.000324	0.000324	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	0.000321	0.000321	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	0.000318	0.000318	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	0.000318	0.000318	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	0.000294	0.000294	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—STAT3—atherosclerosis	0.000291	0.000291	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	0.000284	0.000284	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	0.000278	0.000278	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	0.000275	0.000275	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	0.000271	0.000271	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	0.00027	0.00027	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	0.000257	0.000257	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	0.000255	0.000255	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	0.00025	0.00025	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	0.00025	0.00025	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	0.000231	0.000231	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	0.000229	0.000229	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	0.000219	0.000219	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	0.000212	0.000212	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IL6—atherosclerosis	0.000203	0.000203	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AKT1—atherosclerosis	0.000188	0.000188	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—AKT1—atherosclerosis	0.000176	0.000176	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IL6—atherosclerosis	0.00016	0.00016	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	0.000147	0.000147	CbGpPWpGaD
